vs
Side-by-side financial comparison of iRhythm Holdings, Inc. (IRTC) and SunOpta Inc. (STKL). Click either name above to swap in a different company.
iRhythm Holdings, Inc. is the larger business by last-quarter revenue ($208.9M vs $205.4M, roughly 1.0× SunOpta Inc.). iRhythm Holdings, Inc. runs the higher net margin — 2.7% vs 0.4%, a 2.3% gap on every dollar of revenue. On growth, iRhythm Holdings, Inc. posted the faster year-over-year revenue change (27.1% vs 16.6%). iRhythm Holdings, Inc. produced more free cash flow last quarter ($14.5M vs $12.1M). Over the past eight quarters, iRhythm Holdings, Inc.'s revenue compounded faster (25.8% CAGR vs 7.4%).
iRhythm Holdings is a digital healthcare company focused on cardiac care, developing and commercializing wearable ambulatory heart monitoring devices paired with AI-powered analytical tools. It primarily serves healthcare providers and patients across the United States, helping to detect undiagnosed arrhythmias such as atrial fibrillation through convenient long-term heart rhythm tracking that delivers actionable clinical insights.
SunOpta, Inc. is a multi-national food and mineral company headquartered in Eden Prairie, Minnesota and founded in 1973 in Canada.
IRTC vs STKL — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $208.9M | $205.4M |
| Net Profit | $5.6M | $816.0K |
| Gross Margin | 70.9% | 12.4% |
| Operating Margin | 1.1% | 3.3% |
| Net Margin | 2.7% | 0.4% |
| Revenue YoY | 27.1% | 16.6% |
| Net Profit YoY | 518.5% | 113.1% |
| EPS (diluted) | $0.18 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $208.9M | — | ||
| Q3 25 | $192.9M | $205.4M | ||
| Q2 25 | $186.7M | $191.5M | ||
| Q1 25 | $158.7M | $201.6M | ||
| Q4 24 | $164.3M | $193.9M | ||
| Q3 24 | $147.5M | $175.9M | ||
| Q2 24 | $148.0M | $169.5M | ||
| Q1 24 | $131.9M | $184.4M |
| Q4 25 | $5.6M | — | ||
| Q3 25 | $-5.2M | $816.0K | ||
| Q2 25 | $-14.2M | $4.4M | ||
| Q1 25 | $-30.7M | $4.8M | ||
| Q4 24 | $-1.3M | $-8.7M | ||
| Q3 24 | $-46.2M | $-6.2M | ||
| Q2 24 | $-20.1M | $-5.3M | ||
| Q1 24 | $-45.7M | $2.9M |
| Q4 25 | 70.9% | — | ||
| Q3 25 | 71.1% | 12.4% | ||
| Q2 25 | 71.2% | 14.8% | ||
| Q1 25 | 68.8% | 15.0% | ||
| Q4 24 | 70.0% | 10.9% | ||
| Q3 24 | 68.8% | 13.0% | ||
| Q2 24 | 69.9% | 12.5% | ||
| Q1 24 | 66.3% | 16.8% |
| Q4 25 | 1.1% | — | ||
| Q3 25 | -4.4% | 3.3% | ||
| Q2 25 | -10.0% | 5.5% | ||
| Q1 25 | -20.5% | 5.2% | ||
| Q4 24 | -2.5% | 1.4% | ||
| Q3 24 | -34.1% | 0.5% | ||
| Q2 24 | -15.5% | 1.2% | ||
| Q1 24 | -28.9% | 5.5% |
| Q4 25 | 2.7% | — | ||
| Q3 25 | -2.7% | 0.4% | ||
| Q2 25 | -7.6% | 2.3% | ||
| Q1 25 | -19.3% | 2.4% | ||
| Q4 24 | -0.8% | -4.5% | ||
| Q3 24 | -31.3% | -3.5% | ||
| Q2 24 | -13.6% | -3.1% | ||
| Q1 24 | -34.6% | 1.6% |
| Q4 25 | $0.18 | — | ||
| Q3 25 | $-0.16 | $0.01 | ||
| Q2 25 | $-0.44 | $0.03 | ||
| Q1 25 | $-0.97 | $0.04 | ||
| Q4 24 | $-0.03 | $-0.08 | ||
| Q3 24 | $-1.48 | $-0.05 | ||
| Q2 24 | $-0.65 | $-0.04 | ||
| Q1 24 | $-1.47 | $0.02 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $583.8M | $2.2M |
| Total DebtLower is stronger | — | $250.8M |
| Stockholders' EquityBook value | $152.7M | $162.8M |
| Total Assets | $1.0B | $694.1M |
| Debt / EquityLower = less leverage | — | 1.54× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $583.8M | — | ||
| Q3 25 | $565.2M | $2.2M | ||
| Q2 25 | $545.5M | $2.2M | ||
| Q1 25 | $520.6M | $2.3M | ||
| Q4 24 | $535.6M | $1.6M | ||
| Q3 24 | $522.0M | $2.9M | ||
| Q2 24 | $561.5M | $3.2M | ||
| Q1 24 | $569.1M | $1.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | $250.8M | ||
| Q2 25 | — | $263.3M | ||
| Q1 25 | — | $260.6M | ||
| Q4 24 | — | $265.2M | ||
| Q3 24 | — | $289.9M | ||
| Q2 24 | — | $303.1M | ||
| Q1 24 | — | $258.8M |
| Q4 25 | $152.7M | — | ||
| Q3 25 | $121.9M | $162.8M | ||
| Q2 25 | $103.7M | $159.8M | ||
| Q1 25 | $86.7M | $154.8M | ||
| Q4 24 | $90.9M | $148.6M | ||
| Q3 24 | $71.8M | $155.0M | ||
| Q2 24 | $99.2M | $158.8M | ||
| Q1 24 | $90.3M | $163.6M |
| Q4 25 | $1.0B | — | ||
| Q3 25 | $995.2M | $694.1M | ||
| Q2 25 | $964.0M | $704.9M | ||
| Q1 25 | $926.1M | $690.7M | ||
| Q4 24 | $931.4M | $668.5M | ||
| Q3 24 | $909.7M | $699.3M | ||
| Q2 24 | $919.2M | $704.7M | ||
| Q1 24 | $909.8M | $671.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.54× | ||
| Q2 25 | — | 1.65× | ||
| Q1 25 | — | 1.68× | ||
| Q4 24 | — | 1.78× | ||
| Q3 24 | — | 1.87× | ||
| Q2 24 | — | 1.91× | ||
| Q1 24 | — | 1.58× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $26.2M | $16.3M |
| Free Cash FlowOCF − Capex | $14.5M | $12.1M |
| FCF MarginFCF / Revenue | 6.9% | 5.9% |
| Capex IntensityCapex / Revenue | 5.6% | 2.1% |
| Cash ConversionOCF / Net Profit | 4.70× | 20.03× |
| TTM Free Cash FlowTrailing 4 quarters | $34.5M | $36.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $26.2M | — | ||
| Q3 25 | $34.9M | $16.3M | ||
| Q2 25 | $27.7M | $-4.5M | ||
| Q1 25 | $-7.9M | $22.3M | ||
| Q4 24 | $19.2M | $33.1M | ||
| Q3 24 | $24.3M | $17.2M | ||
| Q2 24 | $11.8M | $-5.6M | ||
| Q1 24 | $-52.0M | $5.3M |
| Q4 25 | $14.5M | — | ||
| Q3 25 | $20.1M | $12.1M | ||
| Q2 25 | $17.3M | $-9.2M | ||
| Q1 25 | $-17.3M | $9.5M | ||
| Q4 24 | $12.4M | $24.0M | ||
| Q3 24 | $15.5M | $11.7M | ||
| Q2 24 | $3.4M | $-15.3M | ||
| Q1 24 | $-61.8M | $-2.3M |
| Q4 25 | 6.9% | — | ||
| Q3 25 | 10.4% | 5.9% | ||
| Q2 25 | 9.3% | -4.8% | ||
| Q1 25 | -10.9% | 4.7% | ||
| Q4 24 | 7.5% | 12.4% | ||
| Q3 24 | 10.5% | 6.6% | ||
| Q2 24 | 2.3% | -9.0% | ||
| Q1 24 | -46.8% | -1.2% |
| Q4 25 | 5.6% | — | ||
| Q3 25 | 7.7% | 2.1% | ||
| Q2 25 | 5.6% | 2.5% | ||
| Q1 25 | 5.9% | 6.3% | ||
| Q4 24 | 4.2% | 4.7% | ||
| Q3 24 | 6.0% | 3.2% | ||
| Q2 24 | 5.7% | 5.7% | ||
| Q1 24 | 7.4% | 4.1% |
| Q4 25 | 4.70× | — | ||
| Q3 25 | — | 20.03× | ||
| Q2 25 | — | -1.03× | ||
| Q1 25 | — | 4.63× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 1.83× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IRTC
| Commercial Payors | $111.7M | 53% |
| Centers For Medicare And Medicaid | $49.2M | 24% |
| Healthcare Institutions | $34.3M | 16% |
| Non Contracted Third Party Payors | $13.7M | 7% |
STKL
| Beverages And Broths | $161.4M | 79% |
| Fruit Snacks | $40.9M | 20% |
| Ingredients | $3.1M | 2% |
